A detailed history of Exane Derivatives transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Exane Derivatives holds 10 shares of RYTM stock, worth $558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10,233 99.9%
Holding current value
$558
Previous $117,000 100.0%
% of portfolio
0.0%
Previous 0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$3.12 - $12.25 $31,895 - $125,231
-10,223 Reduced 99.9%
10 $0
Q1 2022

Apr 22, 2022

BUY
$6.13 - $12.24 $14,387 - $28,727
2,347 Added 29.76%
10,233 $117,000
Q4 2021

Jan 28, 2022

BUY
$8.62 - $13.9 $67,977 - $109,615
7,886 New
7,886 $78,000
Q3 2021

Oct 26, 2021

SELL
$11.68 - $20.72 $60,350 - $107,060
-5,167 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$20.25 - $39.49 $20,391 - $39,766
-1,007 Reduced 16.31%
5,167 $109,000
Q3 2020

Oct 06, 2020

BUY
$18.13 - $30.61 $3,879 - $6,550
214 Added 3.59%
6,174 $133,000
Q1 2020

Apr 17, 2020

BUY
$13.16 - $22.9 $78,433 - $136,484
5,960 New
5,960 $90,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.11B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.